Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 17, 2022Racepinephrine Inhalation SolutionCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1325-2022Class IITerminatedAug 17, 2022Asthmanefrin Racephinephrine Inhalation Solution BronchodilatorCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1324-2022Class IITerminatedAug 17, 2022Dakin's SolutionCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1323-2022Class IITerminatedAug 17, 2022A&D Original OintmentCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1322-2022Class IITerminatedAug 17, 2022Pataday, Once Daily ReliefCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1321-2022Class IITerminatedAug 17, 2022GenTeal TearsCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1320-2022Class IITerminatedAug 17, 2022MiralaxCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1319-2022Class IITerminatedAug 17, 2022Debrox, Carbamide PeroxideCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1318-2022Class IITerminatedAug 17, 2022Systane ZaditorCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1317-2022Class IITerminatedAug 17, 2022Systane BalanceCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1316-2022Class IITerminatedAug 17, 2022Eye-streamCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1315-2022Class IITerminatedAug 17, 2022Systane, Lubricant Eye DropsCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1314-2022Class IITerminatedAug 17, 2022Naphcon A eye dropsCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1313-2022Class IITerminatedAug 17, 2022Bisacodyl SuppositoriesCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1312-2022Class IITerminatedAug 17, 2022Triple Antibiotic OintmentCGMP Deviations: products were stored outside the drug label specifications.Mckesson Medical-Surgical Inc. Corporate Office · D-1311-2022Class IITerminatedAug 17, 2022Lorazepam InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1310-2022Class IITerminatedAug 17, 2022Lorazepam InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1309-2022Class IITerminatedAug 17, 2022Ativan InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1308-2022Class IITerminatedAug 17, 2022Lorazepam InjectionFailed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.Hikma Pharmaceuticals USA Inc. · D-1307-2022Class IITerminatedAug 17, 2022Telmisartan and Hydrochlorothiazide Tablets USPDefective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .Glenmark Pharmaceuticals Inc., USA · D-1306-2022Class IITerminatedAug 17, 2022Telmisartan and Hydrochlorothiazide Tablets USPDefective Container: Recall of these batches has been initiated due to complaints of difficult to open blister and tablet breaks while opening the blister .Glenmark Pharmaceuticals Inc., USA · D-1305-2022Class ITerminatedAug 10, 2022SUSTANGOMarketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.Ultra Supplement LLC · D-1350-2022Class ITerminatedAug 10, 2022SANGTER Energy Supplement CapsulesMarketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.Distributor RFR, LLC. · D-1333-2022Class IIIOngoingAug 10, 2022Tacrolimus OintmentDefective Container: Tube split from side seamGlenmark Pharmaceuticals Inc., USA · D-1304-2022Class IITerminatedAug 10, 2022Matzim LAFailed Dissolution Specifications: below specification limits for dissolution.Teva Pharmaceuticals USA Inc · D-1303-2022Class IITerminatedAug 10, 2022Matzim LAFailed Dissolution Specifications: below specification limits for dissolution.Teva Pharmaceuticals USA Inc · D-1302-2022Class IITerminatedAug 10, 2022Naftifine Hydrochloride GelFailed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention TimeTolmar, Inc. · D-1300-2022Class ITerminatedAug 3, 2022Propofol Injectable EmulsionPresence of particulate matter: particulate identified as a beetle.Pfizer Inc. · D-1301-2022Class IIITerminatedAug 3, 2022Juice BeautyFailed Dissolution SpecificationsEco Lips, Inc · D-1299-2022Class IIITerminatedAug 3, 2022Juice BeautyFailed Dissolution SpecificationsEco Lips, Inc · D-1298-2022Class IITerminatedAug 3, 2022Irbesartan TabletsFailed Dissolution SpecificationsJubilant Cadista Pharmaceuticals, Inc. · D-1294-2022Class IITerminatedAug 3, 2022Irbesartan TabletsFailed dissolution specifications.Jubilant Cadista Pharmaceuticals, Inc. · D-1293-2022Class ITerminatedAug 3, 2022Insulin GlargineLabeling: Missing label: Label missing from some prefilled pens.Mylan Pharmaceuticals Inc · D-1292-2022Class IITerminatedAug 3, 2022Divalproex Sodium Delayed-Release TabletsFailed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.Sun Pharmaceutical Industries Inc · D-1291-2022Class IIICompletedAug 3, 2022Crest 3D White Fluoride Anticavity ToothpasteLabeling: Missing label: the product tube was missing a label and contained a different formulation.The Procter & Gamble Company · D-1290-2022Class IITerminatedAug 3, 2022Testosterone Gel 1%Superpotent Drug: Out of specification assay result was obtained during stability testing.Teva Pharmaceuticals USA Inc · D-1289-2022Class IITerminatedAug 3, 2022Lansoprazole Delayed-Release Orally Disintegrating TabletsFAILED DISSOLUTION SPECIFICATIONSDr. Reddy's Laboratories, Inc. · D-1288-2022Class IITerminatedAug 3, 2022Lansoprazole Delayed-Release Orally Disintegrating TabletsFAILED DISSOLUTION SPECIFICATIONSDr. Reddy's Laboratories, Inc. · D-1287-2022Class ITerminatedAug 3, 2022Nifedipine WSP 0.2% OintmentSubpotent and Superpotent DrugValor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy · D-1286-2022Class IITerminatedJul 27, 2022Launch Sequence Aphrodisia CapsulesMarketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.Loud Muscle Science · D-1341-2022